OX40 ligand: A potential costimulatory molecule in atopic asthma

Journal of Asthma

Volumn 51, Issue 6, 2014, Pages 573-577

  Farres, Mohamed Nazmy ^a   Sabry, Mohamed Kamel ^a   Ahmed, Eman Elsayed ^a   Elkady, Hossam Moustafa ^a   Mohamed, Nesrine Aly ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Asthma; Atopy; Flow cytometry; IgE; OX40L; T helper 2

Indexed keywords

IMMUNOGLOBULIN E; OX40 LIGAND;

ADULT; ALLERGIC ASTHMA; ARTICLE; B LYMPHOCYTE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LUNG FUNCTION TEST; MALE; PRICK TEST; PROTEIN EXPRESSION;

ASTHMA; ATOPY; FLOW CYTOMETRY; IGE; OX40L; T-HELPER 2;

ADULT; ASTHMA; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; OX40 LIGAND; RESPIRATORY FUNCTION TESTS;

EID: 84904088532     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2014.897729     Document Type: Article

References (17)

1. Bousquet J, Mantzouranis E, Cruz AA, A?t-Khaled N, Baena- Cagnani CE, Bleecker ER, Brightling CE, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010;126:926-938.
2. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002;346:1699-1705.
3. Weinberg AD, Evans DE, Thalhofer C, Shi T, Prell RA. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement. J Leukoc Biol 2004;75:962-972.
4. Lane P. Role of OX40 signals in coordinating CD4 T cell selection, migration, and cytokine differentiation in T helper (Th)1 and Th2 cells. J Exp Med 2000;191:201-206.
5. Croft M, So T, Duan W, Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 2009; 229:173-191.
6. Kaur D, Brightling C. OX40/OX40 ligand interactions in T-cell regulation and asthma. Chest 2012;141:494-499.
7. Global Strategy for Asthma Management and Prevention (2009): Global Initiative for Asthma (GINA) NHLB. Available from: http://www.ginasthma.org/ [last accessed January 2014].
8. Siddiqui S, Mistry V, Doe C, Stinson S, Foster M, Brightling C. Airway wall expression of OX40/OX40L and interleukin-4 in asthma. Chest 2010;137:797-804.
9. Ezzat MH, Imam SS, Shaheen KY, Elbrhami EM. Serum OX40 ligand levels in asthmatic children: a potential biomarker of severity and persistence. Allergy Asthma Proc 2011;32: 313-318.
10. Lei W, Zhu CH, Zeng da X, Wang Q, Zhang XQ, Chen YB, Mu CY, Huang JA. SOX40L: an important inflammatory mediator in adult bronchial asthma. Ann Acad Med Singapore 2012;41: 200-204.
11. Arestides RS, He H, Westlake RM, Chen AI, Sharpe AH, Perkins DL, Finn PW. Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002;32:2874-2880.
12. Hoshino A, Tanaka Y, Akiba H, Asakura Y, Mita Y, Sakurai T, Takaoka A, et al. Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma. Eur J Immunol 2003;33:861-869.
13. Salek-Ardakani S, Song J, Halteman BS, Jember AG, Akiba H, Yagita H, Croft M. OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation. J Exp Med 2003;198: 315-324.
14. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, Qin FX, et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005;202:1213-1223.
15. Iyengar SR, Hoyte EG, Loza A, Bonaccorso S, Chiang D, Umetsu DT, Nadeau KC. Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebocontrolled clinical trial. Int Arch Allergy Immunol 2013;162: 89-93.
16. Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005;116: 961-968.
17. Takeda I, Ine S, Killeen N, Ndhlovu LC, Murata K, Satomi S, Sugamura K, Ishii N. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol 2004;172:3580-3589.